Titan Biotech Limited (BOM:524717)

India · Delayed Price · Currency is INR

434.10

+5.65 (1.32%)

At close: Jun 19, 2026

411.73% (1Y)

Market Cap	17.94B +373.2%
Revenue (ttm)	2.06B +31.8%
Net Income	298.85M +38.8%
EPS	7.23 +38.7%
Shares Out	41.32M
PE Ratio	60.04
Forward PE	n/a
Dividend	0.50 (0.12%)
Ex-Dividend Date	Sep 19, 2025

Volume	20,982
Open	429.90
Previous Close	428.45
Day's Range	422.15 - 435.10
52-Week Range	74.73 - 555.65
Beta	-0.53
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; a... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1992

Employees 467

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524717

Full Company Profile

Financial Performance

In fiscal year 2026, Titan Biotech's revenue was 2.06 billion, an increase of 31.79% compared to the previous year's 1.56 billion. Earnings were 298.85 million, an increase of 38.80%.

Financial Statements